Final answer:
The federal statute directly prohibiting the resale of drugs purchased by hospitals or healthcare facilities is not specified. The Pure Food and Drug Act and FDA regulations are related to broader controls over pharmaceuticals but do not directly address resale. Other federal laws, like the Drug Supply Chain Security Act, aim to secure the drug supply chain against illegal drugs.
Step-by-step explanation:
The federal statute that prohibited the resale of drugs purchased by hospitals or healthcare facilities is not explicitly mentioned in the provided information. However, the Pure Food and Drug Act of 1906 established federal standards for drug makers, including ingredient listing, which could loosely relate to the control of drug distribution and thereby potentially touch upon issues of resale. Moreover, the Food and Drug Administration (FDA) plays a key role in regulating the safety and efficacy of the drugs that can be sold in the United States, which indirectly controls the wholesale and resale market as only approved drugs are legally eligible for resale.
Focusing on legislation that pertains directly to the resale of purchased drugs, one would need to consider various federal laws that have been enacted to regulate the pharmaceutical industry. While this response does not provide a specific statute related to hospital drug resale, it's worth noting that laws such as the Drug Supply Chain Security Act (DSCSA) are part of a system to prevent the resale of counterfeit, stolen, or otherwise illegal drugs in the supply chain.